RGC
STJ

Roberts, Glore & Co’s St Jude Medical STJ Stock Holding History

Roberts, Glore & Co’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-8,709
Closed -$698K – 148
2016
Q4 		$698K Sell
8,709
-395
-4% -$31.4K 0.49% 63
2016
Q3 		$726K Sell
9,104
-175
-2% -$14.1K 0.52% 59
2016
Q2 		$724K Sell
9,279
-126
-1% -$8.98K 0.55% 54
2016
Q1 		$517K Buy
9,405
+100
+1% +$5.45K 0.39% 74
2015
Q4 		$575K Buy
9,305
+25
+0.3% +$1.58K 0.43% 65
2015
Q3 		$585K Sell
9,280
-130
-1% -$9.28K 0.46% 61
2015
Q2 		$688K Sell
9,410
-150
-2% -$10.8K 0.48% 61
2015
Q1 		$625K Sell
9,560
-136
-1% -$9.04K 0.43% 70
2014
Q4 		$631K Buy
9,696
+75
+0.8% +$4.83K 0.42% 70
2014
Q3 		$579K Buy
9,621
+66
+0.7% +$4.31K 0.4% 69
2014
Q2 		$662K Sell
9,555
-200
-2% -$13K 0.45% 63
2014
Q1 		$638K Sell
9,755
-200
-2% -$13K 0.44% 68
2013
Q4 		$617K Sell
9,955
-514
-5% -$29.8K 0.43% 65
2013
Q3 		$562K Sell
10,469
-6,220
-37% -$320K 0.41% 66
2013
Q2 		$762K Buy
+16,689
New +$723K 0.47% 61

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Roberts, Glore & Co's STJ Position: Q1 2017 in Review

Roberts, Glore & Co sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 8,709 shares — an estimated $698K sold.

Roberts, Glore & Co first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $762K in Q2 2013. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Roberts, Glore & Co reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Roberts, Glore & Co sold 8,709 St Jude Medical shares in Q1 2017, an estimated $698K.
  • Roberts, Glore & Co first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Roberts, Glore & Co's St Jude Medical position peaked at $762K in Q2 2013.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Roberts, Glore & Co's 13F filing for Q1 2017, filed 15 May 2017.